Fig. 5
Effect of different dose of Naringin 25 mg/kg, Naringin 50 mg/kg, and Naringin 100 mg/kg on the oxidative stress status in CCL2 treated rats. The supernatant of hippocampus homogenate was used for the assay of SOD, GSH-PX activity and MDA levels. A significant increase in (a) SOD and (c) GSH-PX activity in Naringin treatment groups compared with model group. b A significant reduction in MDA levels in Naringin treatment groups compared with model group. Values are expressed as mean ± SEM, n = 8 (#P < 0.05, ##P < 0.01, *P < 0.05, **P < 0.01 vs CCL2)